首页> 美国卫生研究院文献>American Journal of Translational Research >The efficacy of ultrasonic emulsification with IOL implantation in patients with primary angle-closure glaucoma combined with cataract
【2h】

The efficacy of ultrasonic emulsification with IOL implantation in patients with primary angle-closure glaucoma combined with cataract

机译:超声乳化与IOL植入术患者初级角闭青光眼与白内障联合的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: This study aimed to investigate the clinical efficacy of ultrasonic emulsification plus IOL implantation in patients with primary angle-closure glaucoma and cataract. Methods: The clinical data of 81 patients (91 eyes) with primary angle-closure glaucoma comorbid with cataract in our hospital were retrospectively analyzed and divided into two groups based on surgical modality. Group A (n=40, 45 eyes) underwent trabeculectomy and group B (n=41, 46 eyes) underwent ultrasonic emulsification and IOL implantation. The success rate, best corrected visual acuity, intraocular pressure, anterior chamber depth, anterior chamber angle, visual field, cornea’s endothelial cell count, complications, and patient satisfaction were compared between the two groups. Results: The surgical success rate in group B was 97.83%, significantly higher than 86.67% in group A (P < 0.05); Compared with group A, group B had higher best-corrected visual acuity and lower intraocular pressure (P < 0.05) as well as higher central and peripheral anterior chamber depths at 3 months postoperatively (P < 0.05); After surgery, group A had significantly lower postoperative cornea’s endothelial cell count (P < 0.05). Compared with group A, MS was higher and MD was lower in group B at 3 months postoperatively (P < 0.05); the complication rate in group B was 8.70%, lower than 28.89% in group A (P < 0.05). Conclusion: The clinical efficacy of ultrasonic emulsification combined with IOL implantation is remarkable in patients with primary angle-closure glaucoma and cataract, which is conducive to improving postoperative visual acuity, lowering intraocular pressure, increasing the atrial angle, and improving visual field defects. It is also with high safety, but has little effect on cornea’s endothelial cell count.
机译:目的:本研究旨在探讨超声波乳化加IOL植入术患者患者初级角度闭合青光眼和白内障患者的临床疗效。方法:回顾性分析了81名患者(91只眼)的临床资料(91名眼睛),患有白内障的白内障,并根据手术方式分为两组。 A组(n = 40,45只眼)接受了Trabeculectomy和B组(n = 41,46只眼睛)进行超声波乳化和IOL植入。在两组之间比较了两组比较了成功率,最佳矫正视力,眼内压力,前腔深度,前腔体角,视野,角膜内皮细胞计数,并发症和患者满意度。结果:B组的手术成功率为97.83%,显着高于A组的86.67%(P <0.05);与A组相比,B组具有更高的最佳的视力和较低的眼内压力(P <0.05)以及术后3个月的中央和周边前房深度(P <0.05);手术后,A组术后角膜内皮细胞计数明显降低(P <0.05)。与A组相比,MS更高,MD在术后3个月患者B组较低(P <0.05); B组的并发症率为8.70%,A组中低于28.89%(P <0.05)。结论:超声乳化联合IOL植入的临床疗效在初级角闭青光眼和白内障患者中显着,这有利于改善术后视力,降低眼压,增加心房角度,提高视野缺陷。它也具有高安全性,但对角膜内皮细胞计数几乎没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号